Home
About Us
Activities
Guests
Review
Registration
Exhibition
Venues
Contact us
 
 
Guests
 
Ralf Altmeyer Ph.D.
Director General of Institut Pasteur Shanghai
Rolf G. Werner Ph.D.
Senior VP of Boehringer Ingelheim GmbH
Tetsuomi Takano, Ph.D.
Senior Director,Astellas Pharma Inc.
Lily lee Ph.D.
Senior VP Johnson and Johnson
Jing-Shan Hu Ph.D
VP of Bayer Healthcare Pharmaceuticals
Le Sun Ph.D.
President /CEO,Adjunct Prof of VacDiagn Biotechnology Co
Tianmin Zhu Ph.D.
VP, Head of R/D,Zhejiang Hisun Pharmaceutical Co., Ltd
Richard Connell Ph.D.
VP, Head of Research, Asia of Pfizer
Quanming Zou Ph.D.
Director of Clinical Microbiology Immunology, Third Military Medical
Prof. Dexian Zheng
Institute of Basic Medical Sciences Chinese Academy of Medical Sciences
Bradley Marchant, MD
Senior Director, Asia Pacific R/D ofSanofi-Aventis, China
Frank Grams
VP Head Alliance Management of Sanofi-Aventis
Morten Stenkilde Ph.D.
Director, Insulin Filling plant, Novo Nordisk A/S
Barbara VAN WISSEN-BOSCHET
Director of SERVIER France
Allan Riting Liu Ph.D.
VP, Wanbang Biopharm Co. Ltd
Zhou Zeqi Ph.D.
President of Dynamiker Biotechnology (Tianjin)Co.,Ltd
Bin Wang Ph.D.
Fudan University, Shanghai Medical College
Richard Wang, Ph. D.
GlaxoSmithKline Research and Development, CHINA
Mr. Qiang Lü
VP of Yangtze River Pharmaceutical Group
MINGDE XIA Ph.D.
Senior Director of Johnson and Johnson
Prof U.C.E.F. von Arnim
BvA-TeC Fund CEO and Owner at WISRO-International
Maria Song Ph.D.
VP and GM of Venturepharm Group
Chris Mann Ph.D.
Global Lead Scientist, Biotherapeutics of Molecular Devices
Changqing Su Ph.D.
Director, academic leader of Second Military Medical University
Prof Changgeng Ruan
Jiangsu Institute of Hematology
Joe Zhou Ph.D.
CEO of Genor BioPharma Co. Ltd., Wison Group.
Prof. Hanmei Xu
China Pharmaceutical University
Zhenrong Guo Ph.D.
Executive VP,Zhejiang Apeloa Kangyu Pharmaceutical Co.,Ltd
Christopher HUANG, MD
Chairman and Managing Director, Pharmacons
NICK ZHANG Ph.D.
General Manager of QIAGEN (Suzhou) Translational Medicine Company
Mr. Fu Jiemin
Vice General Manager of the Shanghai Fosun Pharmaceutical (Group) CO., LTD
Dr. Yinxiang Wang
CEO and Chief Scientist Officer (CSO) of Zhejiang Beta Pharma, Inc.
Dr. Mingjie Cai
General Manager of Hongye Innovative Antibody Technologies Co., Ltd.
Dr. Hongye Sun
VP of Operation Technology Platform of WuXi Apptec Inc
Dr. Zheng Li
General Manager of Lundbeck Research China
Guoqing Cao, PhD
Vice President of Biology of Jiangsu Hengrui Medicine
Mr. Xinyuan Liu
Academician of CAS Shanghai Institute of Biochemistry and Cell
MS. Ying Ke
VP of Research and Development Management of Shanghai Pharmaceuticals Holding Co., Ltd.
Prof. Wei Guo
Shanghai Ninth People’s Hospital
Jingde Zhu Ph.D.
Shanghai Renji Hospital
Jiping Zha, M.D. Ph.D.
VP of Crown Bioscience Inc.
Daiqing Gao, M.D.
Director of Qingdao Municipal Key Laboratory for Biological Therapies of Cancer
Dr. Jian Ni
The National Engineering Research Center of Antibody Medicine (CMAB) CEO
Dr.Danyi Wen
Shanghai LIDE Biotech Title: CEO
Zhiqiang Ning,MD,PhD
Co-founder and VP of R and D Shenzhen Chipscreen Biosciences Ltd.
Dr. Dan Zhang
Fountain Medical Development Limited CEO
Dr. Shun Luo
President of Jianshun Biosciences Co., Ltd.
Dr Ming-Qiang Zhang
VP of Amgen
Paul R. Eisenberg—SVP
Global Medical Head and Chief Medical Officer
Dr. Wu Jan
University of California, Davis
Dr. Zhijian Lu, PhD
Head of Biologics of China Novartis Institutes for Biomedical Research
Dr. Peng Wang
亚宝药业集团副总裁、研究院院长
The 7rd International Biopharmaceutical Industry Development and Innovation Forum